SAA4 Monoclonal Antibody
- Size: 100ul
- Application: WB, FCM, IHC-P
- Reactivity: Human
- Predicted Reactivity:
-
Datasheet Tech Support
IMAGES
PRODUCT DETAILS
SPECIFICATIONS |
|
---|---|
PRODUCT NAME |
SAA4 Monoclonal Antibody |
CONJUGATION |
Unconjugated |
HOST |
Rabbit |
SOURCE |
Synthetic peptide within C-terminal Human SAA4. |
IMMUNOGEN RANGE |
|
CLONALITY |
Monoclonal |
ISOTYPE |
IgG |
CONCENTRATION |
1ug/ul |
PURIFICATION |
Purified by Protein A. |
STORAGE BUFFER |
Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. |
STORAGE CONDITION |
Store at -20°C for 12 months.. |
TARGET |
|
---|---|
GENE ID |
|
SUBCELLULAR LOCATION |
Secreted |
SYNONYMS |
Amyloid A, serum, 4 antibody, C SAA antibody, C-SAA antibody, Constitutively expressed serum amyloid A protein antibody, CSAA antibody, SAA 4 antibody, Saa4 antibody, SAA4 protein antibody, SAA4_HUMAN antibody, Serum amyloid A 4 protein antibody, Serum amyloid A-4 protein antibody, Serum amyloid A4 constitutive antibody |
BACKGROUND |
SAA4 is a constitutively expressed protein belonging to the SAA family. It is a major acute phase reactant and an apolipoprotein of the HDL complex. The serum amyloid A (SAA) superfamily comprises a number of differentially expressed genes with a high degree of homology in mammalian species. SAA4, an apolipoprotein constitutively expressed only in humans and mice, is associated almost entirely with lipoproteins of the high density range. Its physiological function is unknown and its serum concentration has no relationship with those of other major apolipoproteins. The presence of SAA4 mRNA and protein in macrophage derived foam cells of coronary and carotid arteries suggested a specific role of human SAA4 during inflammation including atherosclerosis. |
APPLICATION DILUTION |
WB(1:300-1000), FCM(1:20-100), IHC-P(1:200-400) |